1.57 (-%)
As of Oct 31, 2024
Source:
Cerus Corp is a biomedical products company focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on our proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion.
Country | United States |
Headquarters | concord, california |
Phone Number | 9252886000 |
Industry | manufacturing |
CEO | William M. Greenman |
Website | www.cerus.com |